AquaBounty Technologies (NASDAQ:AQB) Releases Earnings Results

AquaBounty Technologies (NASDAQ:AQB) posted its quarterly earnings data on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, Zacks reports.

AquaBounty Technologies Price Performance

Shares of NASDAQ:AQB traded up $0.08 during trading on Thursday, reaching $1.07. 590,478 shares of the company were exchanged, compared to its average volume of 20,370. The firm has a market capitalization of $5.51 million, a PE ratio of -0.90 and a beta of 1.39. The business’s fifty day simple moving average is $0.99 and its 200-day simple moving average is $0.96. AquaBounty Technologies has a 12-month low of $0.70 and a 12-month high of $2.95.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Wednesday, July 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, AquaBounty Technologies presently has a consensus rating of “Sell”.

Institutional Trading of AquaBounty Technologies

An institutional investor recently raised its stake in AquaBounty Technologies stock. Renaissance Technologies LLC increased its position in AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 121,585 shares of the company’s stock after purchasing an additional 92,065 shares during the quarter. Renaissance Technologies LLC owned approximately 3.14% of AquaBounty Technologies worth $113,000 as of its most recent SEC filing. 8.92% of the stock is currently owned by institutional investors and hedge funds.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.